...
首页> 外文期刊>Journal of the advanced practitioner in oncology >Assessment of Pathologic Response in Patients With Locally Advanced Rectal Cancer: Implications of the Park et al. Study
【24h】

Assessment of Pathologic Response in Patients With Locally Advanced Rectal Cancer: Implications of the Park et al. Study

机译:局部晚期癌症患者病理反应评估:Park等人的含义。 学习

获取原文
获取原文并翻译 | 示例
           

摘要

Neoadjuvant chemoradio-therapy is considered the current standard of care for patients with locally advanced rectal cancers. The study by Park et al. (2012) discussed by Wolf and Malatek on page 438 represents the largest single-institution study to date evaluating response-stratified outcomes following chemo-radiotherapy and radical resection for patients with clinical stage II or III disease (Park et al., 2012). The findings from the MD Anderson group further validate the growing sentiment that pathologic complete response (pCR) is associated with improved local control and survival. However, questions remain about the practical implications of such data and how having a powerful neoad-juvant treatment response indicator may impact strategies in patient care as well as future research.
机译:Neoadjuvant Chemoradio-Termapy被认为是当前晚期直肠癌患者的当前护理标准。 Park等人的研究。 (2012年)由Wolf和Malatek讨论第438页,代表了迄今为止评价临床阶段II或III疾病患者进行化学放射治疗和激进切除后评估响应分层结果的最大单机研究(Park等,2012)。 MD Anderson组的发现进一步验证了病理完全反应(PCR)与改善的局部控制和生存相关的越来越多的情绪。 然而,仍然存在关于此类数据的实际影响以及强大的新辅助尤文治疗响应指标可能会影响患者护理以及未来研究的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号